Nurix Therapeutics, Inc. (NRIX) Financial Statements (2024 and earlier)

Company Profile

Business Address 1700 OWENS STREET, SUITE 205
SAN FRANCISCO, CA 94158
State of Incorp. DE
Fiscal Year End November 30
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

8/31/2023
Q3
5/31/2023
Q2
2/28/2023
Q1
11/30/2022
Q4
8/31/2022
Q3
5/31/2022
Q2
2/28/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:281,200277,100309,100344,478297,279261,978
Cash and cash equivalents58,95833,57164,47447,55641,53378,780
Short-term investments222,219243,575244,667296,922255,746183,198
Other undisclosed cash, cash equivalents, and short-term investments23(46)(41)   
Receivables     6,000
Deferred costs   500   
Other undisclosed current assets8,81411,2298,84910,3939,51012,506
Total current assets:290,014288,329318,449354,871306,789280,484
Noncurrent Assets
Operating lease, right-of-use asset9,94110,91712,34513,84815,41815,872
Property, plant and equipment18,49517,71717,16316,50115,50713,522
Long-term investments and receivables27,46348,44963,87969,12551,538123,685
Long-term investments27,46348,44963,87969,12551,538123,685
Restricted cash and investments901901901901901901
Other noncurrent assets3,8103,8414,0224,0924,1573,256
Total noncurrent assets:60,61081,82598,310104,46787,521157,236
TOTAL ASSETS:350,624370,154416,759459,338394,310437,720
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities16,07913,80719,56328,09423,75311,301
Taxes payable412653
Employee-related liabilities10,3127,8564,004
Accounts payable4,5255,6295,0646,0536,1426,014
Accrued liabilities11,5548,17814,49911,6889,7291,230
Deferred revenue44,06338,30537,63336,34241,31943,186
Other liabilities1,2441,0201,5031,6542,240551
Other undisclosed current liabilities10,87611,74611,9561,4105,35311,011
Total current liabilities:72,26264,87870,65567,50072,66566,049
Noncurrent Liabilities
Long-term debt and lease obligation:    7,7459,04310,326
Liabilities, other than long-term debt18,44131,22442,40841,54845,86355,428
Deferred revenue14,68326,11835,97441,54845,86355,428
Operating lease, liability3,7585,1066,4347,7459,04310,326
Total noncurrent liabilities:18,44131,22442,40849,29354,90665,754
Total liabilities:90,70396,102113,063116,793127,571131,803
Equity
Equity, attributable to parent259,921274,052303,696342,545266,739305,917
Common stock484747474545
Additional paid in capital728,038719,237709,220700,775578,605571,363
Accumulated other comprehensive loss(1,903)(3,247)(4,319)(3,742)(3,085)(2,066)
Accumulated deficit(466,262)(441,985)(401,252)(354,535)(308,826)(263,425)
Total equity:259,921274,052303,696342,545266,739305,917
TOTAL LIABILITIES AND EQUITY:350,624370,154416,759459,338394,310437,720

Income Statement (P&L) ($ in thousands)

8/31/2023
Q3
5/31/2023
Q2
2/28/2023
Q1
11/30/2022
Q4
8/31/2022
Q3
5/31/2022
Q2
2/28/2022
Q1
Revenues30,67612,6856,78310,79111,4329,621
Gross profit:30,67612,6856,78310,79111,4329,621
Operating expenses(57,441)(55,637)(55,473)(57,509)(57,147)(52,365)
Operating loss:(26,765)(42,952)(48,690)(46,718)(45,715)(42,744)
Loss from continuing operations before equity method investments, income taxes:(26,765)(42,952)(48,690)(46,718)(45,715)(42,744)
Other undisclosed income from continuing operations before income taxes   1,9731,009314211
Loss from continuing operations:(26,765)(42,952)(46,717)(45,709)(45,401)(42,533)
Loss before gain (loss) on sale of properties:(45,709)(45,401)(42,533)
Net loss:(26,765)(42,952)(46,717)(45,709)(45,401)(42,533)
Other undisclosed net income attributable to parent2,4882,219    
Net loss available to common stockholders, diluted:(24,277)(40,733)(46,717)(45,709)(45,401)(42,533)

Comprehensive Income ($ in thousands)

8/31/2023
Q3
5/31/2023
Q2
2/28/2023
Q1
11/30/2022
Q4
8/31/2022
Q3
5/31/2022
Q2
2/28/2022
Q1
Net loss:(26,765)(42,952)(46,717)(45,709)(45,401)(42,533)
Comprehensive loss:(26,765)(42,952)(46,717)(45,709)(45,401)(42,533)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent3,8323,291(577)(657)(1,019)(1,458)
Comprehensive loss, net of tax, attributable to parent:(22,933)(39,661)(47,294)(46,366)(46,420)(43,991)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: